
Supplements and Featured Publications
- New Approaches to the Management and Treatment of Attention-Deficit/Hyperactivity Disorder
- Volume 10
- Issue 4 Suppl
Participating Faculty
The American Journal of Managed Care
This supplement to contains information on the managementand treatment of attention-deficit/hyperactivity disorder.
Faculty
Oscar G. Bukstein, MD, MPH
Associate Professor of Psychiatry
University of Pittsburgh School of Medicine
Western Psychiatric Institute and Clinic
Pittsburgh, Pennsylvania
Mark A. Stein, PhD
Professor of Psychiatry
Director of HALP Clinic and ADHD Clinical Research
Child and Adolescent Psychiatry
The University of Chicago
Chicago, Illinois
Kenneth W. Steinhoff, MD
Associate Clinical Professor
University of California, Irvine
Child Development Center
Irvine, California
Mark Olfson, MD, MPH
Professor of Clinical Psychiatry
Department of Psychiatry
Columbia University
New York, New York
FACULTY DISCLOSURE
The American Journal of Managed Care
It is policy at to have all faculty who participate in programssponsored by corporate organizations disclose any real or apparent conflicts of interest.
- Oscar G. Bukstein, MD, MPHGrant/Research Support From:McNeil Consumer & Specialty PharmaceuticalsNovum PharmaceuticalsSpeakers' Bureau For:McNeil Consumer & Specialty Pharmaceuticals
- Mark A. Stein, PhD Consultant To/Investigator For:Eli LillyConsultant To/Speakers' Bureau For:McNeil Consumer & SpecialtyPharmaceuticalsNovartis
- Kenneth W. Steinhoff, MD Consultant To/Speaker For/Research From:McNeil Consumer & Specialty Pharmaceuticals Speaker For/Research From/Advisor To:LillyConsultant To/Research From:ScheringResearch From/Speaker For:CephalonNovartisResearch Support From:Celltech
- Mark Olfson, MD, MPH Advisor To/Principal Investigator For:Bristol-Myers SquibbCo-Principal Investigator For:LillyOutcomes Research Consultant To:McNeil Pharmaceuticals
The American Journal of Managed Care
Signed disclosures are on file at the offices of , Jamesburg,New Jersey.
This program is being supported by an educational grant from McNeil Consumer & Specialty Pharmaceuticals .
The contents of this supplement may include information regarding the use of products that may beinconsistent with or outside the approved labeling for these products in the United States.Physicians should note that the use of these products outside current approved labeling is consideredexperimental and are advised to consult prescribing information for these products.
Articles in this issue
Newsletter
Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.